The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Every second Wednesday of the month.
So tomorrow I presume.
Adverse media reports?
Any prospective CEO will be aware how shareholders feel as it’s the shareholders who have ousted the present CEO.
I can understand peoples anger and frustration here and that a lot of investments were made based on a faith in Suzy and her ability to grow the share price, but constant attacks and negative comments are not going to benefit any investors.
The company are looking for a new CEO following demands from investors in the company, if you support a replacement CEO then support the company.
Any prospective CEO candidate will probably read this board and would surely be encouraged by positive shareholders rather than a bunch of whining doom mongers.
Sorry about the spelling, either my thumbs are growing or my phone is shrinking!
Let’s have some perspective here!
She has just been ousted from here job, I understand your frustrations but you can hardly expect her to be oozing enthusiasm to a shareholder when its shareholders that have ousted her from her job, she isn’t perfect and was abvioisly inexperienced in a CEO role but don’t blame her for being human.
Https://www.ft.com/content/a6f7fcb6-5580-4fa7-b16b-f7fc8bc650e4
Love how you refer to “we” I think you believe you are a shareholder, but you aren’t are you!
So we know Iceman’s intentions for being on this board, what are yours Porky?
It was a family business, very well thought of in Coventry apparently, from what I have read Adrian de Courcey took the reins in 2010 and ran it successfully until the Pandemic took its toll.
Up until then the business was expanding and doing well, maybe the expansion just at the time of COVID was the problem, he can hardly be blamed for that.
Or another way of looking at it.
The guy ran a successful transport company for many years until the Pandemic ended had a catastrophic effect on business.
Have a look at the fellas CV, it’s pretty impressive!
Don’t tell em Pike!
It would have been a different outcome if the orchestra could fix the whole in the ship.
A net income of at least $750,000 dollars is my understanding.
Euda is the key to Nasdaq listing they have the turnover needed for listing requirements, neither Theoremrx or Valirx have.
I can understand peoples frustration but a little clarity is needed here.
The deadline of 30 + 15 days was to conduct due diligence, that time has passed without any notification for an extension to this, presumably due diligence has been completed.
Last year an announcement was made between Euda and 8i acquisition 2 corp to extend due diligence.
“8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period“
That hasn’t happened here, so I can only presume negotiations are on track and work is still ongoing.
From Eudas announcement re merger in the 5 October
“ The completion of the merger is subject to various conditions, including the negotiation of a definitive agreement, regulatory approvals, and the satisfaction of customary closing conditions.”
The company is led by the industry experienced founder Toby Wilson Waterworth and a Leadership Team with a track record and deep international roots in the pharmaceutical industry.
The team is repeating the success and strategy of its previous venture where it built a diversified late-stage clinical pipeline (leading in Phase 3) through global licensing and clinical development, raising $50M in equity and grants in the process. A top 4 Accountancy firm valued the product pipeline at $500M.
Been pretty quiet today, maybe he has seen the light!
Jwallows has gained the same credibility as Porky!